发明名称 |
COMBINATION THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER 182 |
摘要 |
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof. |
申请公布号 |
HK1208152(A1) |
申请公布日期 |
2016.02.26 |
申请号 |
HK20150108682 |
申请日期 |
2015.09.07 |
申请人 |
GANYMED PHARMACEUTICALS AG |
发明人 |
SAHIN, UGUR;TRECI, ZLEM;MITNACHT-KRAUS, RITA;JACOBS, STEFAN, DENIS;UTSCH, MAGDALENA, JADWIGA;HEINZ, CORNELIA, ADRIANA, MARIA;STADLER, CHRISTIANE REGINA |
分类号 |
A61K;C07K |
主分类号 |
A61K |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|